Letters Breast cancer screening review

The proposed review will not be independent without NICE

BMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d7533 (Published 22 November 2011) Cite this as: BMJ 2011;343:d7533
  1. Karsten Juhl Jørgensen, researcher1,
  2. Peter C Gøtzsche, professor1
  1. 1Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
  1. kj{at}cochrane.dk

Mike Richards and Harpal Kumar, chief executive at Cancer Research UK, were put in charge of the review but neither is independent.

For Richards, this is reflected in the references he chose for his letter.1 The first is used to support his claim of a 35% effect of breast screening in attenders, although they are healthier than non-attenders. The estimate is therefore misleading.

The second …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial